COSCIENS Biopharma Inc. Depreciation Expense
COSCIENS Biopharma Inc. (CSCIF) reported Depreciation Expense of $1.12 million for the 9-month period ending 2024-09-30, per its 6-K filed 2024-11-12.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DepreciationExpense · last filed 2024-11-12
- COSCIENS Biopharma Inc. depreciation expense for the quarter ending 2024-09-30 was $409.00K, a 12.67% increase year-over-year.
- COSCIENS Biopharma Inc. depreciation expense for the quarter ending 2023-09-30 was $363.00K.
| Period end | Depreciation Expense 3 month | Depreciation Expense 6 month | Depreciation Expense 9 month | Depreciation Expense 12 month | Depreciation Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | $409.00K derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $1.12M 6-K · filed 2024-11-12 | |||
| 2024-06-30 | $712.00K 6-K · filed 2024-08-13 | ||||
| 2023-09-30 | $363.00K derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $1.08M 6-K · filed 2024-11-12 | |||
| 2023-06-30 | $721.00K 6-K · filed 2024-08-13 | ||||
| 2022-12-31 | $130.00K 20-F/A · filed 2024-02-15 | ||||
| 2021-12-31 | $129.00K 20-F/A · filed 2024-02-15 | ||||
| 2020-12-31 | $9.00K 40-F/A · filed 2021-03-29 | ||||
| 2019-12-31 | $18.00K 40-F/A · filed 2021-03-29 | $17.00K 20-F · filed 2020-03-31 | |||
| 2018-12-31 | $35.00K 20-F · filed 2020-03-31 | ||||
| 2017-12-31 | $100.00K 20-F · filed 2020-03-31 |